📷 Check out photo highlights from #AIDS2024, including pre-conferences, conference sessions and Global Village activities! You can view photos by day, session or search by keywords! aids2024.smugmug.com

👏 Newly elected IAS Governing Council members assumed their roles at #AIDS2024. We're thrilled to have familiar and new faces joining us for the 2022-2024 term! Learn more about all our Governing Council members now! iasociety.org/governing-coun…

🙋🏿 Want to stay apprised of upcoming IAS conferences, including #HIVR4P2024, #IAS2025 and the #AIDS2026 location announcement? 📨 Join our mailing list now! iasociety.org/newsletter-sig…

IAS President Beatriz Grinsztejn is a leading infectious disease physician-researcher, co-founded Fiocruz HIV/AIDS Service & has served as Director of the HIV/AIDS Clinical Research Unit at INI/Fiocruz for 25 years. Find out more about Beatriz Grinsztejn now! iasociety.org/news-release/b…

#HIVR4P2024 will feature 60+ sessions, including plenary presentations, invited-speaker symposia, oral abstract sessions & satellites! 200+ posters will be presented on site & 300+ virtually. Explore the programme & join in #Lima/virtually this October! programme2024.hivr4p.org

Kawango Agot made invaluable contributions to many IAS Science & AIDS Conferences, including being a track member at #AIDS2024. We will miss her expertise, guidance & commitment not just at our conferences but to the global HIV response.

📣 The IAS continues to call for urgent access to #mpox vaccines across Africa: iasociety.org/ias-statement/…

Dr. Beatriz Grinsztejn is the incoming president of IAS - the International AIDS Society and is this week’s spotlight for #WomenintheLead.

🌟 The IAS Collaborative Initiative for Paediatric HIV Education & Research is launching a new round of research grants for early-stage investigators, working on #paediatric & adolescent #HIV, from low- &/or middle-income countries! ✅ Learn more & apply: iasociety.org/grants/cipher-…

🌐 Join the IAS, GNP+ & ICW on Wednesday, 11 September from 14:00 – 15:00 CEST the third webinar in a series on how to catalyse collective action to eliminate #HIV #stigma & #discrimination. ✅ Register for free now! #PLHIVStigmaIndex iasociety.zoom.us/webinar/regist…

⏪ Take a look back at some of the most memorable moments from #AIDS2024! 📷 Check out our SmugMug account, featuring hundreds of photos from the world's largest conference on #HIV and AIDS! aids2024.smugmug.com

🎞️ As an IAS Member, you have early access to all the session recordings from #AIDS2024! Members can now access all the content: bit.ly/3ZboNX3 ✅ ️Not an IAS Member? Learn about all the benefits and join today: bit.ly/40jLN36

IAS, GNP+ & ICW are hosting a #webinar series exploring ways to strengthen our collective efforts to end #HIV #stigma & #discrimination. Join us on 11 September for the 3rd webinar, "Drawing on data to promote human rights"! #PLHIVStigmaIndex iasociety.zoom.us/webinar/regist…

🗓️ #HIVR4P2024 kicks off in exactly 1 month! ✅ Register now to join us in #Lima, #Peru, or virtually from 6 to 10 October at the only global scientific conference focused exclusively on #HIV prevention research! hivr4p.org

🌐 Join the IAS, GNP+ & ICW today at 14:00 CEST for our #webinar, "Drawing on data to promote human rights & reduce #HIV-related #stigma & #discrimination". Live interpretation will be available in English, French & Arabic. ✅ Register now! iasociety.zoom.us/webinar/regist…

💬 Your words matter. 🌐 Join us in using language that promotes inclusivity, dialogue and equality! #HIVLanguageMatters Iasociety.org/language-matte…

Exciting news! Gilead Sciences has announced PURPOSE 2 trial interim results. 99.9% of cisgender men & gender-diverse people in the #lenacapavir group did not acquire #HIV. These results further strengthen the promise of lenacapavir for HIV prevention: gilead.com/news-and-press…

Full PURPOSE 1 results were shared at #AIDS2024, demonstrating that #lenacapavir provided 100% protection for cisgender women in Africa. The interim results of PURPOSE 2, released today, further reinforce the potential of lenacapavir for #HIV prevention!

Join us at #HIVR4P2024 as we will examine the latest #PURPOSE2 data and explore equitable access to long-acting technologies: hivr4p.org #lenacapavir #PutPeopleFirst Beatriz Grinsztejn

🌐 Join us on 1 October at 15:00 CEST for our #webinar, “#Mpox in focus: Global insights on prevention & treatment”. 👥 It will feature IAS President Beatriz Grinsztejn, Meg Doherty, Dimie Ogoina, Mayara Secco & other leading experts! ✅ Register now: iasociety.zoom.us/webinar/regist…